Načítá se...
Challenges with gonorrhea in the era of multi-drug and extensively drug resistance – are we on the right track?
Neisseria gonorrhoeae has retained antimicrobial resistance to drugs previously recommended for first-line empiric treatment of gonorrhea, and resistance to ceftriaxone, the last option for monotherapy, is evolving. Crucial actions to combat this developing situation include implementing response pl...
Uloženo v:
| Vydáno v: | Expert Rev Anti Infect Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4520807/ https://ncbi.nlm.nih.gov/pubmed/24702589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14787210.2014.906902 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|